United States · FDA National Drug Code directory
Moderna COVID-19 Vaccine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84586-012_326f54a9-8159-1656-e063-6294a90a8002
- Product NDC
- 84586-012
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Moderna COVID-19 Vaccine
- Labeler
- Alloga Logstica Espaa S.L.
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20240820
- Source listing expiry
- 20261231
Source-listed ingredients
- CX-046684 — 25 ug/.25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, PLASTIC in 1 CARTON (84586-012-01) / .25 mL in 1 SYRINGE, PLASTIC (84586-012-02) · 84586-012-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →